Top experts share the latest bladder, kidney and prostate cancer advances from the 2026 ASCO GU Symposium, highlighting patient impact. At the 2026 ASCO GU meeting, experts gathered to share the ...
15h
Clinical trial at Cleveland hospital leads to practice-changing precision prostate cancer therapy
A groundbreaking randomized clinical trial led by Chair of Radiation Oncology Daniel Spratt at University Hospitals Seidman ...
The CAPTAIN trial shows faster recovery, fewer complications, and better early function with the minimally invasive therapy ...
Historically, treatment for metastatic prostate cancer relied heavily on androgen deprivation therapy (ADT) alone. Over time, ...
Prostate-specific membrane androgen PET/CT can help clinicians intensify or de-escalate care for men with prostate cancer who ...
Prostate cancer is the leading cancer among Kenyan men, with an estimated 3,582 men being diagnosed with the disease at some ...
Discusses First Clinical Outcomes and Precision of TULSA from the CAPTAIN Trial in Prostate Cancer March 13, 2026 11:30 ...
Learn how Huntsman Cancer Institute uses cutting‑edge diagnostics and personalized care to treat early‑stage prostate cancer.
Adelaide newsreader Will McDonald has managed his aggressive stage 4 prostate cancer for six years now, although he knows the ...
New formulation of its widely-used U.S. market-leading PSMA PET imaging agent combines thediagnostic performance of PYLARIFY® ...
Prostate cancer is the most common cancer in men throughout the United States. Most men do not realize they have cancer due ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results